Product mentioned on podcasts
Inclisiran
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links. As an Amazon Associate, SignalCast earns from qualifying purchases.
Who mentioned it
“Newer options — oral PCSK9 inhibitor Lerodalcibep, Inclisiran (siRNA mechanism), and Lerodalcibep (ambient-stable, no refrigeration required) — lower ApoB by 50–60% but currently lack equivalent outcomes trials.”
Mentioned on: The Proof